Celiac Disease Diagnosis and Management

Histopathological Features

The gold standard histopathological findings of celiac disease include a spectrum from partial to total villous atrophy, crypt hyperplasia with lengthening, increased lamina propria cellularity, and intraepithelial lymphocytosis (≥25 IELs per 100 enterocytes), according to the American Gastroenterological Association 1, 2
Villous atrophy is required for definitive diagnosis of celiac disease in adults, though lesser degrees of damage (≥25 IELs without villous atrophy) may also indicate celiac disease but should not be considered diagnostic on their own, as recommended by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 3, 1

Biopsy Technique Requirements

Multiple biopsies (ideally 6 specimens) must be obtained from the second part of the duodenum or beyond, as mucosal changes can be patchy and duodenal bulb biopsies may be compromised by Brunner's glands or peptic changes, according to the American Gastroenterological Association 1, 2
Visual endoscopic examination alone is insufficient to rule out celiac disease, as endoscopic appearance of villous atrophy lacks adequate sensitivity, as stated by the American College of Gastroenterology 1

Differential Diagnosis

Medication-induced enteropathy (olmesartan, NSAIDs, mycophenolate mofetil, chemotherapy) can produce villous atrophy with or without increased IELs and must be excluded in seronegative patients, as reported by the European Urology Association 4
Giardiasis, Cryptosporidium (especially in AIDS), and Whipple's disease are infectious causes that can produce villous atrophy with or without increased IELs and must be excluded in seronegative patients, according to the American Gastroenterological Association 1, 4

Management Approach

Strict lifelong adherence to a gluten-free diet is the only effective treatment, requiring immediate referral to a registered dietitian for comprehensive education after biopsy confirmation, as recommended by the American Gastroenterological Association 1
Clinical and histologic response to gluten-free diet confirms the diagnosis in equivocal cases with compatible pathology and HLA haplotypes, as reported by the European Urology Association 4

Role of HLA Testing

HLA-DQ2 and HLA-DQ8 testing has >99% negative predictive value—absence of both alleles virtually excludes celiac disease, according to the American Gastroenterological Association 1
Approximately 95% of celiac patients have HLA-DQ2, and 5% have HLA-DQ8, as stated by the American Gastroenterological Association 1

Diagnostic Pitfalls

Do not diagnose celiac disease based on serology alone without biopsy confirmation in adults (biopsy remains essential except in patients with coagulation disorders or pregnancy), as recommended by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 3
Do not rely on duodenal bulb biopsies alone, as they may miss patchy disease or be confounded by other pathology, according to the American Gastroenterological Association 1, 2

Diagnosis and Management of Celiac Disease

Diagnostic Approach

The American Gastroenterological Association recommends obtaining IgA tissue transglutaminase antibody testing as the most efficient single serologic test for celiac disease, along with measuring total IgA level to rule out IgA deficiency 5, 6
If IgA deficient, the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition suggests obtaining IgG-based tests, which have excellent sensitivity and specificity in this setting 7, 8
The American College of Gastroenterology recommends considering IgA endomysial antibody testing for additional specificity if diagnosis remains uncertain 5, 6

Diagnostic Criteria

The combination of positive celiac serology with villous blunting and increased intraepithelial lymphocytes confirms the diagnosis of celiac disease, according to the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 7, 8
Definitive diagnosis of celiac disease requires villous atrophy, but lesser degrees of damage may also indicate celiac disease, as stated by the American Gastroenterological Association 9, 7

Differential Diagnosis

Medication-induced enteropathy, Helicobacter pylori gastritis, small intestinal bacterial overgrowth, and autoimmune enteropathy should be considered as common causes of villous atrophy with negative celiac serology, according to the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 9, 7, 8
Giardiasis, post-infectious enteropathy, and tropical sprue are infectious causes that must be excluded, as recommended by the American College of Gastroenterology 9, 7, 8

Management

The American College of Gastroenterology recommends initiating a strict gluten-free diet immediately after biopsy confirmation as the only effective treatment for celiac disease, with referral to a registered dietitian for comprehensive dietary education 10
Screening for nutritional deficiencies, evaluating for associated autoimmune conditions, and follow-up serologic testing are essential components of management, according to the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition 10

Critical Pitfalls to Avoid

The American Gastroenterological Association advises against initiating a gluten-free diet before completing diagnostic workup, as this leads to false negative serology and inconclusive biopsies 10
Ensuring adequate biopsy sampling and confirming proper orientation of biopsy specimens are crucial for accurate diagnosis, as stated by the American College of Gastroenterology 5, 6, 11

Celiac Disease Diagnosis with Positive Serology and Negative Duodenal Biopsy

Primary Diagnostic Approach

The American Gastroenterological Association recommends that in patients with strongly suspected celiac disease and negative biopsies, positive tissue transglutaminase-IgA (tTG-IgA) should still be performed, and repeat biopsies should be considered either immediately or in the future 12, 13
Patients must consume at least 10g of gluten daily for 6-8 weeks before biopsy to avoid false-negative results, as recommended by the American Gastroenterological Association 12, 13

Serologic Thresholds That Support Diagnosis

When tTG-IgA levels exceed 10 times the upper normal limit combined with positive endomysial antibody (EMA) in a second blood sample, the positive predictive value for celiac disease is virtually 100%, according to the American Gastroenterological Association 12, 13
Endoscopy and duodenal biopsies may be performed primarily for differential diagnosis purposes rather than to confirm celiac disease, as suggested by the American Gastroenterological Association 12, 13

Algorithm for Managing Discordant Results

Confirm the patient was consuming adequate gluten (≥10g daily) for at least 6-8 weeks when biopsies were performed, as recommended by the American Gastroenterological Association 12
Measure total IgA levels to exclude IgA deficiency, which occurs in 1-3% of celiac patients and causes falsely negative IgA-based tests, according to the American Gastroenterological Association 12, 13

Critical Pitfalls to Avoid

The American Gastroenterological Association recommends that capsule endoscopy is not recommended for making the initial diagnosis of celiac disease, even with positive serology and negative standard endoscopy 14
Do not start a gluten-free diet before completing the diagnostic workup, as this leads to false-negative serology and inconclusive biopsies, as advised by the American Gastroenterological Association 12, 13

Monitoring Strategy

Persistently positive serology usually indicates ongoing intestinal damage and warrants continued investigation, according to the American Gastroenterological Association 12, 13

Celiac Disease Diagnosis and Management

Diagnostic Criteria

The British Society of Gastroenterology recognizes that lesser degrees of intestinal damage, such as increased intraepithelial lymphocytes (≥25 IELs per 100 enterocytes), may indicate celiac disease, even in the absence of villous atrophy 15, 16, 17
Patients with positive celiac serology (IgA-EMA, tissue transglutaminase, or IgG-DGP) and increased intraepithelial lymphocytes (≥25 IELs per 100 enterocytes) may be classified as having "probable celiac disease" and should be offered a trial of gluten-free diet to support the diagnosis 15, 16

Diagnostic Algorithm

The American Gastroenterological Association acknowledges that villous atrophy is required for definitive diagnosis, but earlier stages of celiac disease exist, and patients with mild enteropathy (increased IELs without villous atrophy) require treatment 15, 17
HLA-DQ2 or HLA-DQ8 testing has >99% negative predictive value, and absence of both alleles virtually excludes celiac disease, with approximately 95% of celiac patients having HLA-DQ2, and 5% having HLA-DQ8 15, 17

Differential Diagnosis

Other causes of increased IELs without villous atrophy, such as medications (NSAIDs, PPIs, olmesartan, mycophenolate mofetil), infections (Helicobacter pylori gastritis, Giardiasis, post-infectious enteropathy), autoimmune conditions (common variable immunodeficiency, autoimmune enteropathy), and other conditions (small intestinal bacterial overgrowth, food protein intolerances), should be excluded before diagnosing probable celiac disease 17, 18
Notably, 16% of cases initially presenting as lymphocytic duodenosis were ultimately found to have celiac disease in one study 19, 18

Differential Diagnosis of Villous Atrophy with Negative IgA TTG

Introduction to Seronegative Enteropathy

Seronegative celiac disease remains the most common cause of seronegative enteropathy, representing up to one-third of cases in White patients, according to the American Gastroenterological Association 20, 21

Diagnostic Considerations

The American Gastroenterological Association recommends confirming total IgA level, as IgA deficiency occurs in 1-3% of celiac patients and causes false-negative IgA-based tests, with IgG-based tests (IgG TTG, IgG DGP, IgG EMA) ordered if IgA is low or absent 22, 20, 23
Verify biopsy orientation by having an experienced GI pathologist review the specimens to confirm true villous atrophy versus tangential sectioning artifact, as recommended by the American Gastroenterological Association 20, 23
Check complete celiac serology panel, including IgA DGP and IgA EMA, in addition to IgA TTG, as suggested by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition 22, 20

Primary Differential Diagnosis

Seronegative celiac disease represents up to 33% of seronegative enteropathy cases in White populations, according to the American Gastroenterological Association 20, 21
Order HLA-DQ2/DQ8 testing, as approximately 95% of celiac patients have HLA-DQ2 and 5% have HLA-DQ8, with absence of both alleles having >99% negative predictive value, as recommended by the American College of Gastroenterology 21
If HLA-DQ2/DQ8 positive, consider empiric trial of strict gluten-free diet for 6 months with clinical and histologic monitoring, as suggested by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition 20, 23

Medication-Induced Enteropathy

Review medication history specifically for olmesartan, NSAIDs, mycophenolate mofetil, and chemotherapy agents, which can cause medication-induced enteropathy, according to the American Gastroenterological Association 22, 24

Infectious Causes

Order targeted testing based on clinical context, including stool antigen or PCR for giardiasis, and consider small bowel aspirate if bacterial overgrowth is suspected, as recommended by the Infectious Diseases Society of America 22

Immune-Mediated Disorders

Look for specific histologic clues, such as absent/reduced plasma cells in lamina propria on biopsy, and order confirmatory tests, including immunoglobulin levels, as suggested by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition 22, 23

Inflammatory Bowel Disease

Consider Crohn's disease, looking for granulomas on biopsy, and perform colonoscopy with ileoscopy and imaging, as recommended by the American Gastroenterological Association 22, 23

Diagnostic Algorithm

Verify IgA level and complete celiac serology panel (IgA/IgG TTG, DGP, EMA), and order HLA-DQ2/DQ8 testing, as suggested by the American College of Gastroenterology 20, 23, 21
Review medications and discontinue potential offenders, and order infectious workup, including stool studies for Giardia and Cryptosporidium, as recommended by the American Gastroenterological Association 22

Critical Pitfalls to Avoid

Do not assume negative serology excludes celiac disease, as seronegative celiac disease is common, according to the American Gastroenterological Association 20, 21
Do not miss IgA deficiency, always checking total IgA level with IgA-based tests, as recommended by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition 22, 20
Do not rely on subjective response to gluten-free diet alone, as this has poor predictive value, and histologic response is required for confirmation, as suggested by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition 20, 23
Do not overlook medication history, as olmesartan and NSAIDs are frequently missed causes, according to the American Gastroenterological Association 22
Do not accept poorly oriented biopsies, as tangential sections can mimic villous atrophy, and always have an experienced GI pathologist review, as recommended by the American College of Gastroenterology 20, 23